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Abstract
TCR ALPHA LCR AND NON-LCR CIS-ELEMENTS CONTRIBUTING TO TISSUE
SPECIFIC EXPRESSION OF THE TCR ALPHA GENE IN THYMIC AND PERIPHERAL T
CELLS
by
Martina Kučerová-Levisohn
Adviser: Dr. Benjamin Ortiz

Orchestrated expression of multiple genes residing in the complex TCRα/δ/Dad1 locus requires
tight control from multiple cis-acting elements. The TCRα locus control region (LCR), is
positioned between TCRα and Dad1 gene, and has been implicated in the differential expression
of both genes. In this study, we focus our work on the hypersensitive site (HS)1 prime (HS1’),
located 3’ of the classical Eα enhancer, within the TCRα LCR. We investigated its nonredundant role in TCRα expression in thymic and peripheral T cells as assayed by in vivo and in
vitro studies. Furthermore, formation of HS1’ in both lymphoid and non-lymphoid tissue raised
the possibility of HS1’ playing a dual role in regulating both the upstream (TCRα) as well as the
downstream (Dad1) genes. To answer this question, we created wild type and mutant HS1’ dualreporter BACs utilizing human and rat CD2 reporter genes in the position of TCRα and Dad1,
respectively. We find HS1’ important for TCRα expression in thymus and spleen T cells, but
dispensable for Dad1 expression. We widened our focus to include sequences outside of the
TCRα LCR. Specifically, DNase I hypersensitivity assay revealed a cluster of active chromatin
just 5’ of the constant region Cα exons. Analysis of this 3.9-kb region using a BAC transgenic
mouse model reveals its importance for TCRα gene expression in thymic and splenic T cells.
iv

Interestingly, this novel DNase hypersensitive regulatory complex will remain present upon the
Vα-Jα rearrangement of the TCRα gene given its location 3’ of the most downstream functional
joining (J) segment, Jα2. Therefore, the novel cis-acting region may contribute to endogenous
TCRα gene activity.
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Chapter 1: INTRODUCTION

1.1 Murine TCRα /TCRδ/Dad1 Locus
Mouse chromosome 14 contains the complex T-cell receptor (TCR)-α/δ/Defender against Death
(Dad)-1 locus that displays a unique layout of differentially expressed genes. Tight gene
regulation must be orchestrated during development to lead to functional rearrangement and
tissue specific expression of TCRα/δ genes and ubiquitous expression of Dad1 gene. TCRα/δ
genes encode the TCRα and TCRδ protein subunits of the T cell receptor of two distinct lineages
of T cells, αβ and γδ. V(D)J rearrangement of the TCRβ and TCRδ gene precedes rearrangement
of the TCRα gene. TCRδ rearranges at double negative DN2 stage [1] that is marked by absence
of the CD4 and CD8 cell surface markers, whereas TCRα rearranges at a later time point,
between DN4 [2-4] and DP (CD4+/CD8+) stage [2,4]. TCRα activation coincides with onset of
the TCRα LCR activity [5]. The α chain of the TCR is formed by recombination of one variable
(V) and one joining (J) gene segment to the constant region Cα. The δ chain has additional
diversity (D) gene segments; therefore the δ chain rearranges the V(D)J gene segments to Cδ.
The majority of circulating T cells belong to the αβ lineage. Successful rearrangement of the α
chain deletes δ gene segments since the Vδ, Dδ, Jδ, Cδ are located between the Vα and Jα
segments. The rearrangement of the TCRδ and TCRα gene is catalyzed by RAG1/2 enzymes and
is controlled in cis [6].
Defender against death 1 (Dad1) is an anti-apoptotic gene that was discovered in a temperature
sensitive mutant cell line [7]. Later on, Dad1 was confirmed to encode a mammalian subunit of
oligosaccharyltransferase (OST) enzyme, that is involved in N- linked glycosylation [8]. As
1

polypeptides are synthesized from the mRNA they are translocated across the endoplasmic
reticulum (ER) membrane into the lumen, where they are modified by the OST enzyme. Nlinked glycosylation is crucial for the efficient folding and assembly of the newly synthesized
polypeptides [9]. Without Dad1, the essential cellular functions fail, resulting in programmed
cell death [8,9]. Deletion of Dad1 gene results in early embryonic lethality [10,11]. Dad1 is
highly conserved in vertebrates, invertebrates and plants [7,9,10]. Dad1 is ubiquitously expressed
with Dad1 mRNA transcripts detected as early as day E6.5 [11]. Furthermore, the expression of
Dad1 gene is regulated during the course of the T cell development, with highest expression
levels occurring at the SP stage of T cells [11]. However, it is unknown, what exact role Dad1
plays in the T cell development. Overexpression of Dad1 leads to increased proliferation of
peripheral T cells upon antigen stimuli [11].
Since TCRα and Dad1 gene have different gene expression profiles and functions, they might be
controlled by a cis-acting regulatory element called a Locus Control Region (LCR) that resides
between the two genes. The TCRα LCR’s influence on the TCRα is known, however regulation
of Dad1 gene has not yet been determined.

1.2 TCRα Locus control region
The TCRα locus control region (LCR), residing between the TCRα and Dad1 gene [12], is a
powerful cis-acting DNA element that has been studied in context of a linked heterologous
transgene. The LCR manifests its powers by providing high expression levels of the transgene at
all integration sites (integration site- independence) of transgenic animal that confer to the
spatiotemporal control of the given LCR [13,14]. TCRα LCR allows the TCR genes to be
expressed specifically at T cells at time of DN to DP stage transition. Lastly, the expression of
2

the transgene will positively correlate with the transgene’s copy number that the particular
transgenic mouse line carries [13,14].
TCRα LCR consists of nine DNaseI hypersensitive sites (HS) that, as assayed, contain highly
accessible form of chromatin that stretches over a ~13.5-kb large region [12,15]. The known
function of individual sites (if already determined) will be reported in the order of their position
starting from the 5’ end.
HS7 and HS8, located on the most 5’ end of the TCRα LCR are thought to contain silencer
elements [16], however, they are not required for full LCR activity [15].
HS1 was discovered by transient transfection assay [16] and is the classical enhancer Eα that is
an integral part of the LCR since its deletion leads to a loss of strict copy number-dependency,
one of the characteristic traits of LCRs [15]. It also ensures the highest-level thymic expression
of an LCR- linked transgene [15].
HS1 prime (HS1’) was discovered as a cluster of a few HS sites that forms strongly in both
lymphoid and non-lymphoid tissues [15,17] and is highly enriched in histone H3 acetylation
[18]. CCCTC-binding factor (CTCF) dependent enhancer blocking activity was observed in
HS1’ [18] and its role in LCR activity was already tested in vivo. It was found that the CTCF and
5’CTCF-like containing sequences are not required for full LCR activity. Only minor effects on
transgene expression levels (per copy) were observed with maintained tissue-specificity [19].
HS1’ site is a focus of one of my projects and is further described in chapter 5.
HS2-6 of the TCRα LCR provides an open chromatin environment and this region is crucial for
protection from the position effect variegation (PEV) that results in gene silencing and absence
3

of transgene expression if integration occurs at a site of heterochromatin [20]. Therefore, this 3’
portion of the LCR (HS2 through HS6) carries the hallmark of the LCR’s integration site
independence. Without the 5’ portion (HS1 and HS1’) of the LCR that specifically increases
expression of the transgene in the thymus and inhibits non-lymphoid organ transgenic
expression, chromatin conformation assayed by the DNaseI hypersensitivity assay remains in
open configuration in both non-lymphoid and lymphoid tissue [20].
HS4 is located ~3.8-kb away from HS1’, it is differentially methylated in lymphoid and
non-lymphoid organs. In lymphoid organ HS4 site is hypomethylated [21] and highly enriched in
histone acetylation [18]. Both modifications are associated with open chromatin state.
Transgenic mice with an internal deletion of the HS4 region exhibit decreased transgene
expression in thymus and abnormal expression in different organs with large variability [19].
Therefore, HS4 region is needed to protect transgene expression from PEV. Interestingly, HS4
differential methylation is lost upon HS1’ site removal, linking these two sites.
HS6 is a well-characterized site of the TCRα LCR by in vivo and in vitro assays. HS6 site
alone can suppress PEV and is a source for wide chromatin opening activity [22]. Furthermore,
in vivo occupied factor-binding sites were identified in thymus (thymic footprint (TF) 1-2-3) and
were determined to bind AML-1/RUNX and Elf-1 [22], proteins known for their interaction with
chromatin remodeling complexes [23,24]. Once again, HS1’ was required for tissue specific
factor occupancy in the identified footprint. Removal of TF1-2-3 sites resulted in decreased
expression of the reporter gene (per copy) as assayed in a transgenic mouse model and in the
formation of inaccessible chromatin configuration where HS4 site was not formed and HS1 and
HS1’ were weak [25]. Furthermore, in vitro assay in NIH 3T3 cells identified an additional site
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3’ of the TF 1-2-3 (site HS6-316) that is functional in support of wide chromatin opening
activity. Together, this data indicate a great importance of HS6, it’s dependence on HS1’ and
HS6 influence on HS4 and HS1, HS1’ regions [25].
From the structure/function analyses of the TCRα LCR, a scenario emerges of a great interplay
among the individual HS sites that function in harmonic synergy to bring about the
developmentally appropriate, tissue specific expression of the TCRα gene and Dad1 gene.

1.3 Gene regulation of the TCRα locus
Regulation of gene expression in thymocytes is a complex process involving multiple cis
elements such as promoters, enhancers and locus control regions. Additionally, trans elements
including transcription factors, chromatin-remodeling complexes and histone-modification
enzymes are essential for proper gene regulation [26]. For example, T cell development requires
Notch signaling that initiates (T vs. B cells) [27] and sustains differentiation in addition to
transcription factors such as GATA-3, E2A/HEB, c-Myb, Runx1, TCF-1 and Ikaros that are
expressed at different times during differentiation [28].
Enhancers, originally defined by transient transfection gene assays using differentiated cell lines,
function in an orientation independent manner. Enhancers increase transcriptional initiation from
promoters and may be located near or far away from promoters, docking site of RNA
Polymerase II. Enhancers might directly interact with promoters leading to transcriptional
activation, for example in our locus Eα has been shown to directly interact with TEA promoter
[29] in order to initiate germline expression of J regions. This model is termed “looping” and
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was described in late 1990’s by the Groudine lab [30] and received abundant support from 3C
(chromosome conformation capture) [29] and 3D-FISH studies [31-33].
Transcription and recombination of the locus is greatly influenced by DNA packaging into
chromatin in the nucleus. The nucleosome is the fundamental unit of chromatin. 147 bp large
segments of DNA are wrapped tightly around the histone octamer (H2A, H2B, H3 and H4).
Multiple, reversible covalent modifications (eg. acetylation and methylation, phosphorylation
and ubiquitination) can be introduced post-transcriptionally to histone tails that alter chromatin
structure and/or recruit proteins [34]. Chromatin then can exist in either condensed chromatin
(heterochromatin) associated with silent genes, or loose, decondensed (euchromatin)
configuration occurring in expressed genes. It has been determined that inaccessibility of gene
locus to nuclease (e.g. DNaseI) and DNA methylation, catalyzed by methyltransferase enzyme,
are associated with silenced genes [35]. On the other hand, hypomethylation, DNase I
accessibility and histone acetylation are associated with actively transcribing genes. Moreover,
“active” markers (e.g. H3K4me3) or “repressed” (e.g. H3K27me3) marks contribute to
chromatin configuration. However, histone marking cannot always be interpreted in such a
straightforward manner. Furthermore, it has been shown that a “poised” state exists for some
enhancers where presence of H3K4me1 or H3K4me2 in absence of H3K27ac is noted on the
histone tail of progenitor cells [36]. Bivalent chromatin structure with both activating H3K4me3
and repressing H3K27me3 modifications at the same site has been shown in embryonic stem
cells and is thought to provide flexible platform for later developmental state [37].
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TCRα gene is a developmentally regulated gene that will become active at the ~ DP stage of the
T cell development and undergo V(D)J rearrangement. Differentiating T cells can be easily
monitored and separated based on their expression of cell surface markers (see chapter 3).

1.4 LCRs
The first discovered LCR came from the human β-globin gene locus. Puzzling over the lack of
transcription of intact β-globin genes in transgenic mice [38-40], and certain thalassemia patients
[41,42], an important regulatory element (eventually termed an LCR) was discovered 5’ of the
human β-globin genes [43]. Since then, a few additional LCRs and LCR-like elements have been
found (reviewed in [13,14]). Immunologically relevant genes have been a fruitful source of
LCRs: human CD2 [44], perforin (PRF1) [45], human MHC class I HLA-B7 [46], macrophage
lysozyme [47], mouse TCRγ [48], human T cell-specific adenosine deaminase [49] are a few
examples. Our work presented below comes from the TCRα LCR [12] and its surrounding locus.

7

Chapter 2: MATERIALS AND METHODS

2.1 DNA constructs
TCRα /Dad1 bacterial artificial chromosome (BAC) dual-reporter constructs
Wild type BAC
The BAC utilized in this study is based on a TCRα/Dad1 genomic region-containing subfragment [50] of clone RP23-94I14 (BACPAC Resources, Oakland, CA). Our BAC fragment
spanned from the extreme 3’- Jα region to approximately 38-kb downstream of the Dad1 exons.
BAC modifications were done using Red/ET recombination technology (Gene Bridges)
following the manufacturers instructions. The (approximately 5.4-kb) genomic human CD2
(ghCD2) reporter gene [51] driven by a 429-bp Vα17 promoter sequence (minimal promoter
established by Dr. Armin Lahiji, Vα17 promoter was a kind gift from Dr. Derek Sant’Angelo),
was inserted approximately 3.7-kb upstream of exon 1 of the TCRα constant region in the
transcriptional orientation of the TCRα gene. The second reporter gene was a 703-bp cDNA of
the rat CD2 (rCD2) gene [52] linked to an SV40 poly-adenylation signal (from pEYFP-C1). This
reporter was recombined in frame to ATG in exon 1 of the Dad1 gene. Thus, the Dad1 promoter
drives transcription of the rCD2 reporter gene. Prior to transfection, the dual-reporter BAC
construct fragment was released from the pBACe3.6 vector backbone using NotI and FseI
restriction enzymes and separated by Field-Inversion Gel Electrophoreses (FIGE). The 76.2-kb
band was isolated from the gel by electro-elution into TE buffer followed by phenol/chloroform
extraction and ethanol precipitation.
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Mutant BACs (Δ HS1’BAC and Δ Jα 3_Cα 1 BAC)
Two mutant version of the wild type BAC were created using Red/ET recombination technology
(Gene Bridges). Both mutant versions utilize the same dual-reporter genes (ghCD2 and rCD2) as
described above. Deleted regions are as follows: one, HS1’ site (BglII–BamHI) of the TCRα
LCR was removed, creating a deletion of 826-bp, that lead to the ΔHS1’ BAC construct. Second,
the Jα3-Cα1 mutant BAC has a deletion of 3.9-kb region spanning from 38-bp 5’ of a SacI site
[53] (located between Jα4 and Jα3) to 9-bp 3’ of an EcoRV site within the Cα constant region
exon 1. This deletion removed the identified cluster of DNaseI hypersensitive sites described in
chapter 6. The ~75.4-kb (ΔHS1’ BAC construct) and ~72.5-kb (ΔJα3_Cα1 BAC construct)
bands were isolated from the gel by electro-elution into TE buffer followed by
phenol/chloroform extraction and ethanol precipitation.
hCD2:1-8 and hCD2:1-8ΔHS1’ constructs
hCD2:1-8 construct was previously described [5]. Briefly, ~10.5-kb SalI–BamHI fragment of the
hCD2 reporter gene (lacking the cytoplasmic tail responsible for signaling of the CD2 molecule)
was positioned 5’ of the 10.2-kb SalI– SacI fragment of TCRα LCR (all 9 HS of the TCRα LCR
are included). hCD2:1-8ΔHS1’ construct has 826-bp of BglII–BamHI sequence removed,
corresponding to the HS1’ site of the TCRα LCR. DNA fragments containing transgene
cassettes for transfections were liberated from the pBluescript (Stratagene) vector by digestion
with SalI and NotI restriction enzymes. In order to obtain purified fragments for transfection,
samples were run on 1% low-melting-point agarose (Sea Plaque), excised and followed by βagarose digestion (NEB) and ethanol precipitation.
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Neomycin-G418 resistance cassette
A 1.6-kb Neomycin-G418 resistance cassette driven by the SV40 promoter was excised from the
pEYFP-C1 vector (Clontech) using SspI and EcoO109I restriction enzymes, run on 0.8% agarose
gel and the DNA fragment was column purified (Qiagen). The gel purified Neomycin-G418
resistance cassette was used for co-transfection purposes in equimolar amounts to the construct
during ESC transfections.

2.2 Transgenic mice

The purified DNA constructs were microinjected into male pronuclei of (C57BL X CBA) F1
fertilized eggs and transferred to pseudo-pregnant females at the MSKCC facility. Transgenic
founders were identified by Southern blot and PCR screening. Founders were then outcrossed to
C57BL/6 mice (Taconic) to establish individual transgenic mouse lines. The relative transgene
copy numbers among the individual mouse lines were determined by Southern blot and qPCR.
~10 µg of tail genomic DNA was digested with AflII restriction enzyme overnight. After
electrophoresis and transfer to nitrocelluose membrane, Southern blot was performed. A 508-bp
large probe corresponding to 3’ end AflII fragment was prepared by PCR and double labeled
with [α-32P] dATP and [α-32P] dCTP using RadPrime DNA Labeling System (Invitrogen by Life
Technologies) before hybridization. Relative copy number for each BAC transgenic mouse line
was determined from three Southern blots, simultaneously detecting transgene and endogenous
locus (band of different sizes) and quantified by PhosporImager.
Samples of mouse tail genomic DNA (5ng) were prepared with mix of DyNAmo HS SYBR
Green qPCR Kit (New England BioLabs) and qPCR was done in an Applied Biosystems 7500
10

RT-PCR device. Relative copy numbers were determined using the comparative ΔΔC(t) method
with mouse GAPDH as a normalizer. The primers used were as follows: mGAPDH forward: 5’cctctgcgcccttgagctagga-3’ mGAPDH reverse: 5’-cacaagaagatgcggccgtctc-3’. To detect BAC,
primers were designed at the most 5’ end of the construct (Vα17 promoter forward, reverse) and
the 3’ end region (Dad1 forward, reverse). Since primers amplify endogenous as well as
transgene sequence, any DNA sequence detected above the non-transgenic sample correspond to
additional sequences due to presence of the transgene. The non-transgenic control value obtained
represents two (endogenous) copies and was set to 1. The primers used were as follows: Vα17
fw1:

5’-ctgcttaagattcactttcaccag-3’,

rev:

5’-caactgcacttctgagagctgc-3’,

Dad1

fw:

5’-

gagcagcatttctaaacccgc-3’ Dad1 rev: 5’-ttccacatcccacccactctac-3’. Sample values from three
experiments for each primer combination in duplicates were averaged to obtain relative copy
numbers for individual transgenic mouse lines. Results from the three Southern blots and from
the qPCR analyses were similar.

2.3 Embryonic stem cell (ESC) culture, transfection and in vitro differentiation

Undifferentiated mouse embryonic stem cells (ESR1) were cultured on top of Mitomycin C
arrested mouse embryonic fibroblasts (Millipore) monolayer in Dulbecco’s Modification of
Eagle’s Medium (DMEM) with high glucose and sodium pyruvate (Corning) with additional
supplement of 20% ES cell qualified FBS (Fetal bovine serum) (Gemini), 1% Glutagro
(Corning), 1% Penicillin/Streptomycin (Corning), 1% HEPES (Millipore), 1% nonessential
amino acids (Millipore), 0.1% gentamicin (Life Technologies), 0.1% (55 µM) β-mercaptoethanol
(Life Technologies), and 10 ng/ml LIF (Millipore).
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About 1.0 X 107 ES cells were transfected using a Bio-Rad Gene Pulser at the setting of 0.24 kV
and 500 µF in 0.5 ml electroporation buffer (Millipore) with 12 µg of BAC or 10 µg of the
hCD2:1-8ΔHS1’ fragment and each of the reporter gene constructs were co-transfected with an
equimolar amount of the neomycin-G418 resistance cassette. The G418 selection was done 24hours post transfection at the concentration of 0.35 mg/ml for first 2 days followed by decrease
to 0.175 mg/ml of G418 for the rest of the selection; with change of selection media daily.
Individual ESC colonies were picked after 7-10 days and were clonally propagated. Presence of
the hCD2 transgene in drug-selected ES cell clones was detected by PCR using the following
primers: fw: 5’-gaggaaaccaacccctaagatgag-3’ and rev: 5’- cgtaatctctttggagactgcacc-3’ detecting
the 5’-end portion of the hCD2 gene. PCR positive clones were further screened on Southern blot
for intactness of the transgene. The copy number of individual ES clones was determined from at
least three Southern blots after digestion of genomic DNA samples with BglII and probed from
3’-end with 827-bp probe [5] located in HS6 region of the TCRα LCR to detect intact head to
tail configuration of the transgene and quantified using PhosphorImager. For BAC ES cells,
screening was done with Vα17-forward primer: 5’-atcctgtcacttcagctagcc-3’; hCD2ΔT-reverse:
5’-cgtaatctctttggagactgcacc-3’ and rCD2 specific primers (see below). Southern blots were done
to confirm presence of transgene and estimate relative copy number.
In vitro differentiation of ESC to T cells was previously described [54] and our modification to
the existing protocol (see chapter 3) was described in detail in literature [55,56] as well as in a
video-documented journal [57]. Selected ESC clones carrying hCD2:1-8ΔHS1’construct were
differentiated into T cells alongside a non-transfected ESR1 as a negative control and previously
published [55] hCD2:1-8 ESC (clones A1, B5, D6) served as positive controls and expression
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baseline for comparing mutant clones.

2.4 Bone marrow derived hematopoietic stem cell and in vitro differentiation on
OP9-DL1 cells

In vitro differentiation of HSC purified from bone marrow was performed as previously
described [54]. WT BAC line 36 and non-transgenic littermate control were used for the
experiment. Bone marrow (from femur and tibia of 8 weeks-old mice) was flushed out using a
syringe and recovered cells were MACS purified using Lineageneg cell kit (Milteneyi). Lineageneg
(CD4, CD8, CD11b, CD19, CD45R, CD161, Gr.1, Ter119) cells were seeded on OP9-DL1
monolayers and supplemented with 5 ng/mL Flt-3L and 1 ng/mL IL-7 and passaged every 4-5
days to fresh OP9-DL1 monolayer. Day 11 and day 12 of the co-culture, the IL-7 cytokine
concentration was lowered to 0.5 ng/mL and 0.25 ng/mL, respectively and cells with both
cytokine concentrations were kept in parallel. The progress of the co-culture was monitored by
flow cytometry.

2.5 Flow cytometry

Mice
~1x106 of single cell suspension thymocytes or splenocytes from BAC transgenic mouse lines
were pretreated in with 100 µL of FACS staining medium (RPMI 1640 supplemented with 3%
FBS and 10mM HEPES buffer) for 10 min at 4°C along with 1µg of rat anti-CD16/32 (Clone
2.4G2, Life Technologies) to block Fc receptors. Afterwards, 0.2-.5 µg of the Abs (from BD
Biosciences) were added and incubated for 20 min at 4°C, followed by three washes with FACS
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staining medium. For detection of our reporter genes on the cell surface, FITC conjugated mouse
anti-human CD2 (clone S5.2) or mouse anti-rat CD2 (clone OX-34) were used in combination
with rat anti- mouse CD4 (clones GK1.5 or RM4-5) conjugated to APC and rat anti-mouse
CD8α (clone 53-6.7) conjugated to PE; or hamster anti-mouse TCRβ chain (clone H57-597)
conjugated to APC and rat anti-mouse CD19 (clone1D3) conjugated to PE. Samples were
acquired using FACSCalibur (BD Biosciences) device and collected data was analyzed with
FlowJo (Tree Star) software.
Co-culture
The progress of the ESC differentiation toward the T cells was monitored by flow cytometry on
crucial days of the co-culture: day 12, 15/16 and 20/21 using 5 channels of the FACScan device.
All antibodies used were obtained from BD Biosciences or Life Technologies. First, the Fc
receptors were blocked by pretreating the cells with anti-CD16/32 (Clone 2.4G2) for 10-20’;
followed by addition of antibodies conjugated to a particular fluorochrome. The following
antibodies were used: anti-human CD2 (clone S5.2) or anti-rat CD2 (clone OX-34) conjugated to
FITC for reporter gene detection on cell surface and anti-mouse CD45 (Clone 30-F11)
conjugated to PE or APC, CD44 (Clone IM7) conjugated AF700, CD25 (Clones 3C7 or PC61)
conjugated to PE or APC, CD8 (Clone 53-6.7) conjugated to PE, CD4 (Clones GK1.5 or RM4-5)
conjugated to AF700, CD11b (clone M1/70.15) conjugated to PE, Ter119 (clone TER119)
conjugated to AF700 to distinguish particular stages of hematopoiesis during ESC
differentiation. Dead cell discriminator (DCD) from Invitrogen was used to label the non-viable
cells and remove them from the subsequent analyses with FlowJo (Tree Star) software. Samples
were acquired on the FACScan device.
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2.6 RNA isolation and detection

BAC transgenic mice: RNA Analysis by Northern blots
RNA was prepared from PBS-rinsed mouse organs (thymus, kidney, lung, liver and heart) using
the single step RNA isolation protocol [58]. 5-10 µg of total thymic RNA was run on 0.8%
agarose gel and transferred to neutral nylon membrane (Amersham) for Northern blot analysis.
Hybridization probes were labeled with [α-32P] dATP and [α-32P] dCTP using RadPrime DNA
Labeling System (Invitrogen by Life Technologies). To detect hCD2 transgene RNA, a labeled
500-bp EcoRV-PstI fragment of hCD2 exon 2 was added during hybridization. A 699-bp NcoISalI fragment was used for rCD2 transgene RNA detection. Both Northern blots were
normalized to 18S rRNA to control for loading and efficiency of transfer. Ten pmol of the highly
specific 18S rRNA 20-mer 5’-cggaactacgacggtatctg-3’ probe [59] was end-labeled using γ-32P
ATP and T4 polynucleotide kinase (New England Biolabs). PhoshorImager analyses were used
to obtain normalized transgene expression levels (per copy) for individual mouse lines.
BAC transgenic mice: RNA Analysis by qRT-PCR
RNA samples from thymus and purified spleen T cells were isolated using RNeasy Mini Kit
(Qiagen). Spleen T cells of >91% purity were obtained using magnetically activated cell
separation (MACS, Miltenyi Biotec) system. cDNAs was synthesized from RNA using the
QuantiTect Reverse Transcription Kit (Qiagen) with genomic DNA Wipeout Buffer or the
ProtoScript kit (NEB). Expression of the hCD2 transgene was detected with hCD2-specific
primers described previously [55]. Levels of rCD2 expression was detected with the following
rCD2-specific primers: fw: 5’-ccagtgccttgttcaggatacg-3’, rev: 5’- ggagtttctttctgctcttcagcc-3’.
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Endogenous Dad1 expression levels were used as a normalizer in these experiments using a
forward primer specific for exon 1 that are not present in the BAC reporter: (5’tgcagttcggctactgtctcc- 3’) and a reverse primer complimentary to Dad1 exon3 (5’ggaaagtaagggctacagtgagg-3’). Samples of cDNA were prepared with mix of DyNAmo HS
SYBR Green qPCR Kit (New England BioLabs) and qRT-PCR experiments were carried out in
ViiA7 system (Applied Biosystem) or Applied Biosystems 7500 device.
OP9 co-cultulture derived T cells: RNA Analysis by qRT-PCR
For each clone, on the final day 20/21 of the co-culture, RNA was isolated by utilizing the
RNeasy Micro Kit (Qiagen). 0.5-1.0 µg total RNA was reverse transcribed to c-DNA using
ProtoScript kit (NEB). Expression of human CD2 transgene was detected with hCD2 primers
[55], TCRα primers [50] were used to normalize for loading variation, content and stage of
differentiation of T cells in co-culture. Relative hCD2 transgene levels were determined by the
comparative ΔΔC(t) method as previously described [55,56]. Samples were mixed with
DyNAmo HS SYBR Green qPCR Kit (New England BioLabs), run in duplicates and three
repetitions were performed in ViiA7 qPCR system (Applied Biosystem).

2.7 DNaseI Hypersensitivity Assay

Nuclei of MACS purified spleen T cells from C57BL/6 mice were subjected to DNaseI titration
(Worthington). The reaction was performed on ice and stopped after 10 min by adding 1/10
volume of stop buffer (5% SDS, 100mM EDTA). Proteinase K (200 µg/ml) was added to
samples and incubated overnight at 55°C. This was followed by phenol/chloroform extraction
and ethanol precipitation of DNaseI-treated genomic DNA. These samples were then digested
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with the NdeI restriction enzyme to generate a 6.7-kb parental fragment of the endogenous JαCα region. Samples were loaded on 0.8% agarose gel, run and transferred to positively charged
nylon membrane (Nytran SPC) for Southern blot analysis. A 669-bp probe was generated by
PCR using the parent BAC clone as a template and the following primers: fw: 5’atggctgagggaaaggtctacg-3’ and rev: 5’-agaaaagtctctgggaactggtgtc-3’. The probe was labeled with
[α-32P] dCTP and/or [α-32P] dATP using the RadPrime DNA Labeling System (Life
Technologies).
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Chapter 3: In vivo and in vitro model systems

3.1 Transgenic Mouse Model and in vitro ES cell differentiation model

Two methods of analyzing the activity of the TCRα LCR and non-LCR elements were employed
in these studies. The gold standard in the field of LCRs for many decades has been the transgenic
mouse model. This method provides a very powerful approach, in which individual transgenic
lines are established, each representing an independent genomic integration point of the tested
construct. However, this model can be rather slow, expensive and “tricky” if the transgenic
founders don’t transmit or stop breeding. Unfortunately, this statement foreshadows some of our
results.
A second method, an in vitro embryonic stem cell (ESC) differentiation, was validated just last
year in our lab [55]. All hallmarks of the LCR (integration independent expression in copy
number dependent manner of the linked reporter gene with tissue specific and correct
developmental timing) were manifested. Therefore, this model can stand on its own, however,
for this study, it is used as supplemental method for our in vivo study. The OP9-DL1 system for
in vitro differentiating ESC to T cells [54] is an elegant, faster approach and supplements our
transgenic studies, where each generated ES clone is “equivalent” to individual mouse, carrying
the construct at a different integration site.
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3.2 20 days in a dish, the journey from ES cell to T cell

Embryonic stem cells (ES cells) are harvested from the inner cell mass (ICM) of the blastocyst.
ES cells are self-renewing, totipotent cells that can contribute to all tissue types (germ cells
included) of the animal if injected back to the blastocyst [60]. We utilized the murine R1/E ES
cells that were derived from 3.5 day blastocyst of the 129 mouse strains cross and were kind gift
from the J. C. Zúñiga-Pflücker lab (University of Toronto). ES cells are selected and propagated
on a confluent monolayer of irradiated or Mitomycin C arrested mouse embryonic fibroblast
(MEFs) with addition of the leukemia inhibitory factor (LIF) [61] to keep cells in an
undifferentiated state (Figure 1).

F IGURE 1. Undifferentiated mouse ESC. Phase contrast microscopy image of undifferentiated
mESCs (sharp edged colonies) growing on top of a MEF monolayer (100x magnification).
(Originally published in JoVE [57].)

We start the process of the in vitro differentiation with drug-selected, stably transfected ES cells
that carry intact reporter gene cassettes. ESC clones are seeded on a bone marrow stromal cell
line, OP9 that does not expresses the macrophage colony-stimulating factor (M-CSF) [62] due to
M-CSF gene mutation [63], and thereby allows commitment to the hematopoietic lineage
[64,65]. These cells are marked by cell surface expression of Flk-1 [66].
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If ES cells are left “without direction”, they proliferate and spontaneously differentiate into
embryoid bodies (EB) - cystic structures that are characterized by semi-organized germ layers
tissues [67], including the mesoderm that will give rise to hematopoietic precursors [68-70].
Therefore, ES cells are left (free of external, additional cytokines) to form mesoderm for length
of 5 to 7 days [56,57]. This is one of the crucial steps in this co-culture method, since the
majority (80-90%) of ES cells colonies need to be visually inspected to confirm mesoderm
formation before proceeding with the co-culture (Figure 2).

F IGURE 2. Mesoderm formations. Phase contrast microscopy images of mesoderm-like colony
formation at “day 5” of co-culture. (A) 40x and (B) 100x views of co-culture plates with >90%
mesodermal colony differentiation. These plates are ready for day 5 passage. (C-F) Examples
of Day 5 co-culture plates that require 1-2 day postponing before transfer (C&E, 40x
magnification, D&F, 100x magnification). (Originally published JoVE [57]).
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It’s important to visually monitor the progress of the co-culture and develop an eye for
recognizing mesoderm formation (either “wagon wheel” or “florets” can form) [57,71] (Figure
3).

F IGURE 3. Morphology of mesoderm. Phase contrast microscopy images of the variety of
mesoderm-like colony formations at day 5 of co-culture. (A) The colony morphology referred
to as “craters” or “wagon wheel.” (B) The colony morphology referred to as “starburst” or
“florets” (200x magnification). (Originally published JoVE [57].)

Culturing ES cells on an OP9 monolayer would not achieve full-scale differentiation to T cells
[72], rather it would drive differentiation towards monocytic, erythroid and B cell lineages. T
cells do not develop in the bone marrow; T cell precursors migrate to thymus to complete their
development. It is therefore important to “mimic” the thymic environment with its essential
factors in the in vitro studies as well. This was accomplished by retroviral transduction of the
OP9 cell line with the Notch ligand Delta-like 1 (OP9-DL1) that provides necessary signals for
full T cells differentiation [73]. In addition, an optimal lot of fetal bovine serum (FBS) and
cytokines are necessary for successful and robust differentiation.
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In vitro differentiation cultures are provided with fms-like tyrosine kinase 3 ligand (Flt3-L)
starting on “day 5 passage” since Flt-3L is important for differentiation to lymphohematopoietic
progenitors [65]. By day 8, semi-adherent hematopoietic progenitor cells (HPC) are at the
crossroad for myeloid and B cell or T lymphoid lineage. HPCs are collected and cells that will be
induced to T cell lineage are transferred to OP9-DL1 monolayers [73], whereas for monocytic,
erythroid or B cell lineage, cells are kept on OP9 monolayers [65]. In both cases, in vitro cocultures are supplemented with Flt-3L and, starting from day 8, interleukin 7 (IL-7).

3.3 Monitoring in vitro co-culture progress by flow cytometry

Flow cytometry analyses can be utilized to monitor the progress of the co-culture. All cells are
initially gated with forward and side-scatter on lymphocyte population, followed by live-gate
(DCDneg or DAPIneg) before analyses.
Cells undergoing differentiation on the OP9 monolayer will yield erythroid (CD45neg, TER119+)
and monocytic (CD45+, CD11bhi) lineages on day 12 and B cells (CD45+, CD19+) by day 16.
Cells differentiating on OP9-DL1 monolayers will first go through double negative (DN) stages
of T cell development that are characterized by absence of the CD4 and CD8 cell markers and
can be further divided to four stages DN1-4. Day 12 yields DN1 (CD44+, CD25neg, CD4neg,
CD8neg) and DN2 (CD44+, CD25+, CD4neg, CD8neg) stage T cells, day 16 yields DN3 (CD44neg,
CD25+, CD4neg, CD8neg) and DN4 (CD44neg, CD25neg, CD4neg, CD8neg) stages. Some DP (CD4+,
CD8+) T cells can also begin emerging by day 16 but large amounts of DP T cells and single
positive (SP) CD8+ T cells are not present until day 20 of the co-culture. SP CD4+ T cells do not
form in this system. This limitation is thought to be partially due to the lack of major
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histocompatibility complex (MHC) Class II molecule on cell surface of the OP9 cells [74] that
are necessary for positive selection of helper T cells (CD4+) [75].
Figure 4 summarizes the key steps of the in vitro differentiation procedure, suggested analysis
time points and lineage expectations during the time of co-culture.
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F IGURE 4. Diagram of the steps of the mESC-OP9 co-culture procedure. (A) The key cell
transfer steps during the first eight days of co-culture. The approximate number of cells seeded
on OP9 cells at days zero and five are indicated. (B) The day 8 transfer step and the expected
cellular differentiation products detected by flow cytometry at key time points of co-culture.
Please see text for detailed descriptions of the immunophenotypes. (Originally published JoVE
[57].)
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Chapter 4: Mimicking the complexity of the TCRα/Dad1 locus by utilizing a dual-reporter
BAC construct.

4.1 Construct design of wild type dual-reporter BAC

Uniquely positioned and differentially expressed genes in the TCRα/Dad1 locus call for complex
and tight gene regulation that must be orchestrated during development to lead to functional
rearrangement and tissue specific expression of TCRα and TCRδ genes, and ubiquitous
expression of Dad1 gene.
Previously, single reporter genes have been utilized in TCRα LCR transgenic mouse studies.
Originally, the 4.9-kb BglII fragment of the human β-globin (including the promoter, exons,
introns and 3’ enhancer) linked to the TCRα LCR [15,19,20,25] was utilized. This reporter was
replaced by cell surface-detectable ~10.5-kb SalI-BamHI fragment of genomic hCD2 reporter
[5,55,56]. In addition, 6.5-kb EcoRI genomic fragment of the human leukocyte antigen-B7
(HLA-B7) reporter gene [46] was also utilized but unfortunately did not surface for antibody
detection [50]. All reporters gene listed had a desired pre-requisite; poor expression without
additional elements [38-40,44,46,76,77] that makes them greatly suitable for LCR studies.
Prototype of the dual-reporter BAC system [50] developed by Dr. Stefan Knirr gave expected, T
cell specific expression pattern to the upstream reporter and ubiquitous expression to the
downstream reporter. In addition, low (rather than high) ectopic B cell expression was seen
(improvement from previous single reporter genes). Unfortunately, aberrant splicing occurred
rendering the Vα11.1 driven hCD2 reporter gene (c-DNA) undetectable on the cell surface [50].
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Our latest model (work done with Dr. Stefan Knirr), a BAC dual-reporter gene version 2 (see
material and method section) is used in this study. We are utilizing the genomic human CD2
(ghCD2) reporter gene [51] driven by a 429-bp Vα17 minimal promoter sequence positioned to
~3.7-kb upstream of exon 1 of the TCRα constant region in the transcriptional orientation of the
TCRα gene. The second reporter gene is a 703-bp cDNA of the rat CD2 (rCD2) gene [52] that
utilizes the Dad1 promoter for its transcription (Figure 5).

F IGURE 5. A dual-reporter BAC. Diagram (not to scale) of the dual-reporter BAC construct
for detecting the products of a Vα promoter driven human CD2 reporter gene (Vα17 ghCD2),
and a Dad1 promoter-driven rat CD2 (rCD2) reporter cDNA (Dad1 rCD2) [52].The numbered,
dark boxes indicate the exons of the hCD2 reporter gene, TCRα constant region (Cα) and Dad1
gene. The ‘dot’ in Exon 5 of the hCD2 gene indicates a premature stop codon that results in
production of a non-signaling hCD2 protein [51]. The light box indicates the TCRα LCR
sequences. The numbered, vertical arrows indicate DNase I hypersensitive sites in the region
of the LCR. Eα refers to the classical transcriptional enhancer element of the TCRα gene. The
position of the FseI and NotI restriction sites used to excised the BAC reporter fragment for
microinjection (or before transfection) are shown. (Originally published in Journal of
Immunological Methods [56].)

4.2 Wild type dual reporter BAC carrying TCRα LCR exhibits integration site
independent expression

Since our dual-reporter wild type BAC construct carries the full length TCRα LCR with
additional surrounding sequences (5’-end reaching Jα3 proximal SacI site [53], the 3’-end ~38kb downstream of Dad1 gene) totaling in ~77-kb, we fully expect uniform, integration site
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independent expression of the upstream (TCRα reporting) hCD2 gene as per defining LCR
property of position-effect suppression that was demonstrated numerous times [5,20,50,55]. The
downstream (Dad1 reporting) rCD2 gene is expected to be ubiquitously active [50].
Four independent BAC transgenic mice lines (lines 36, 42, 62 and 71) carrying the TCRα/Dad1
dual-reporter BAC constructs in 4, 7, 3 and 2 copies; as well as three independent ESC clones
(clones 15, 17 and 68) carrying the exact same construct but with 2, 4, 3 copies, are analyzed
here by flow cytometry. All seven independent integration sites are permissive for hCD2
expression. rCD2 expression is expected rendering active Dad 1 promoter. rCD2 expression is
detected in all mouse lines and clones, albeit at low levels; this may be due to cDNA rCD2
reporter gene rather than genomic version (Figure 6).

F IGURE 6. A TCRα /Dad 1 gene locus-derived dual reporter BAC construct is expressed
independently of genomic integration site. Flow cytometry detection of TCRα reporter
(hCD2) and Dad1 reporter (rCD2) activity. (A) CD4/8 DP T cells (dark curves) derived in vitro
from three independent, BAC-transfected ESC clones. The light curves represent the signals
from control, non-transfected ESR-1 cell-derived DP T cells assayed in parallel. (B) Spleen T
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cells (TCRβ + ) from the indicated, independent wild type (Wt) dual-reporter BAC transgenic
mouse lines. Reporter gene expression in transgenic (solid line) and non-transgenic control
(dashed line) cells is shown. (Panel A originally published in Journal of Immunological
Methods [56].)

4.3 Tissue/cell type specificity of the Wild type BAC

Furthermore, thymic and in vitro derived T cell specific expression is expected of the hCD2
reporter gene under the influence of the TCRα LCR. rCD2 reporter gene is expected to be
expressed in all tissues/organs examined, as well as to be detectable in all phenotypic cells
emerging from differentiating co-culture.
qRT-PCR analyses of the hCD2 reporter mRNA levels from organs/tissues of four WT BAC
transgenic mice revealed expected tissue distribution with the maximal thymic expression (set to
100%). Very low expression (<4% of the thymic levels) was detected in the non-lymphoid
organs (ranging from 1.9% in kidney to 3.8% in heart). Transgene mRNA levels were
normalized to β-actin (Figure 7A). This thymus specific tissue distribution of the hCD2
transgene under the TCRα LCR influence concurs with previously published data [5,20,50].
Northern blot analyses were carried out to examine the tissue distribution of the rCD2 reporter
gene. rCD2 mRNA levels were normalized to 18S ribosomal RNA signal. Figure 7B shows two
representative transgenic lines (line 36 and 42) with the ubiquitous distribution of the rCD2
expression. PhosphorImager analyses of the rCD2 mRNA levels and its expression pattern in
organs of four wild type BAC transgenic mice are shown in Figure 7C.
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F IGURE 7. Expression pattern of tissue distribution of the dual-reporter transgene in the
wild type BAC. Analyses of reporter mRNA levels in lymphoid (thymus) and non-lymphoid
(kidney, lung, liver, heart) organs of Wt transgenic mice. (A) qRT-PCR analyses of human
CD2 (hCD2) reporter gene (black bars) normalized to β-actin in the indicated tissues. Observed
mRNA levels are expressed as a percent of that observed in thymus. The average relative
mRNA levels of the four wild type BAC transgenic mouse lines are plotted. (B) Northern blot
analyses of the rat CD2 (rCD2) reporter gene in indicated organs from representative Wt BAC
transgenic mouse (line 36 and 42). 18S rRNA is used as a loading control. (C) PhosphorImager
analyses of Northern blots assessing the rCD2 expression (white bars) in different organs of
the wild type BACs (n=4). Transgene levels are normalized to 18S rRNA and expressed as a
percentage of the organ with the highest level of reporter expression for each line.
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Similarly, the three ESC clones differentiated in vitro to T cells show no expression of hCD2
outside of T lymphocytes (expressing DP T cell population is shown). No hCD2 expression was
detected in monocytic or erythroid progenitor cells (Figure 8). On the other hand, as expected,
the rCD2 expression was detected (at low but uniform levels) in all examined cells (Figure 8).

F IGURE 8. Cell type distribution of TCRα /Dad1 BAC reporter gene activity. Flow
cytometry detection of TCRα reporter (hCD2) and Dad1 reporter (rCD2) in the indicated in
vitro differentiation progeny of a representative dual-reporter BAC transfected ESC clone
Wt68. Representative gating (shown at left) of day 12 co-cultures (for erythroid, monocytic
and DN1 T cells) and day 20 co-cultures (DP T cells). Signals from the progeny of transfected
cells are shown by the dark curves. The light curves represent the signals from control, nontransfected ESR-1 cell-derived progeny assayed in parallel with transfected clones. (Originally
published in Journal of Immunological Methods [56]).
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From the above data, we conclude that the tissue specific expression of the upstream hCD2 and
ubiquitous expression of the downstream rCD2 reporter is maintained in the WT BAC,
mimicking the endogenous TCRα/Dad1 expression pattern.

4.4 TCRα /Dad1 dual-reporter BAC follows correct developmental timing

See chapter 3 for detailed explanation of cell surface marker distribution. Briefly, as the early
common lymphoid progenitors (CLP) seed the thymus, they undergo developmental progression
through the immature stages that are marked by absence of the CD4 and CD8 cell markers and
are commonly referred to as double negative (DN) cells. This developmental stage can be further
divided based on expression of CD25 and CD44 molecules to DN1-DN4. TCRα genes are the
last to rearrange (in doing so, the TCRδ genes embedded between the Vα and Jα segments are
removed) to replace the pre-Tα surrogate leading to αβ TCRs. The rearrangement of the TCRα
occurs in transition between the DN to DP stage of the T cell development [4]. We therefore
expect to see up regulation of the hCD2 reporter gene at this transitional stage. Similar kinetics
are shown with a single reporter gene linked to the TCRα LCR in vitro [55] and in vivo [5]. In
sharp contrast to hCD2 reporter, we expect rCD2 to exhibit early onset and widespread pattern of
expression (shown in figure 8), since Dad1 gene is ubiquitously expressed, with mRNA
transcripts detected as early as day 6.5 of mouse embryonic development [11].
To determine the developmental timing of the onset of the reporter genes, one can isolate the
small population of double negative (DN) CD4neg/CD8neg cells from the mouse thymocytes
utilizing magnetically activated cell sorting (MACS), and stain for CD44 and CD25 cell surface
markers that will distinguish early stages of T cell development. Alternatively, the onset of
31

expression can be observed in the differentiating co-culture by flow cytometry. The co-culture
can be initiated from WT BAC-transfected ESC clones as described in chapter 3 or initiated from
HSC-derived from the bone-marrow of the transgenic animal [54]. (See material and methods
section for brief description of this procedure.)
Developmental progress of the three independent WT BAC ESC clones was monitored in the in
vitro co-culture assay and cells collected to detect various developmental stages (FACS day 12,
16 and 20). We show the expected upregulation of the hCD2 reporter at the DN3 stage of the T
cell development (Figure 9).

F IGURE 9. Flow cytometry detection of the developmental timing TCRα reporter (hCD2)
expression. Analyses of differentiating T cell progeny of a representative dual-reporter BAC
transfected ESC clones. Representative gating of day 12 (DN1 and DN2), day 16 (DN3) and
day 20 (DP) ESC-OP9DL1 co-cultures is shown at left. Reporter hCD2 gene signals from the
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indicated T cell progeny of transfected cells are shown by the dark curves. The light curves
represent the signals from control, non-transfected ESR-1 cell-derived progeny assayed in
parallel. (Clone WT15 was part of a figure published Journal of Immunological Methods [56].)

Similarly, in vitro differentiation of HSC obtained from bone marrow of WT BAC transgenic
line 36 (and non-transgenic littermate control) on the OP9-DL1 stromal monolayer shows
upregulation of the hCD2 reporter gene at the same stage (DN3) (Figure 10). This experiment
was performed together with Ph.D. student, Joe Giovinazzo, rotating in our lab and sharing his
expertise in bone marrow removal. Optimization of the IL-7 concentration is necessary for the
bone marrow-derived HSC differentiation [54]. Standard amount of 1ng/ml of IL-7 added
starting day 8 is kept constant during in vitro ESC to T cell differentiation. However, for the
bone marrow derived HSC in vitro differentiation, the co-culture progress benefits greatly from a
decrease of IL-7 starting day 12 [54]. Decreasing of the IL-7 concentration is necessary for more
rapid progress of earlier progenitors to enter DP (CD4+/CD8+) stage of differentiation [54]. In
our hands, the 0.25 ng/mL IL-7 concentration was optimal and lead to increased number of DP T
cells compared to the co-culture carried with higher IL-7 concentration (Figure 10 far right).
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F IGURE 10. Proper TCRα -like timing of the hCD2 reporter gene is observed during T cell
development in the wild type BAC. (Top) Flow cytometric analysis of hCD2 transgene
expression during thymocyte development initiated from a bone marrow of WT BAC (line 36)
and non-transgenic littermate control using the in vitro OP9-DL1 differentiation system.
Representative gates are shown for each collected time-point. Day 7 represents T cells in DN1
and DN2 stages of the T cell development. Day 11 revealed DN2 and DN3 and by day 21 T
cells progress to various numbers of DP (CD4 + /CD8 + ) cells depending on the concentration of
IL-7 (see text). Please see text for detailed descriptions of the immunophenotypes. (Bottom)
Histograms displaying hCD2 reporter gene expression during DN1 to DP stage transition of
developing T cell from the wild type BAC (dark curve) and its non-transgenic littermate
control (light curve).

4.5 High expression of hCD2 reporter in BAC is comparable in thymic and
peripheral T cells

Size is the one great advantage and disadvantage of the BAC constructs. Since BACs can
accommodate large portions of DNA, we were able to include a large portion of the TCRα/Dad1
locus. However, this makes BACs hard to manipulate. Previously, in peripheral T cells, lower
than expected levels of simple TCRα-LCR driven reporter gene expression were detected
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(ranging from 15-46% of thymic expression levels), whereas, the endogenous TCRα mRNA
levels were upregulated in peripheral T cells [5]. Since two different reporters were utilized (βglobin and hCD2), an argument was made against reporter gene-specific effects. It was thought
that other elements, in the wider TCRα locus, are responsible for supporting the highest-level
peripheral TCRα expression [5].
Utilizing our WT BAC that spans from the extreme 3’- Jα region to approximately 38-kb
downstream of the Dad1 exons, we took the opportunity to return to the question of the
peripheral T cell expression. We compared hCD2 expression levels in thymocytes and purified
spleen T cells of the four WT BAC transgenic mice. qRT-PCR analyses show that the β-actin
normalized hCD2 expression level of peripheral T cells were comparable to thymic levels. On
average, ~ 71% of thymic levels were detected in spleen T cells (Figure 11). This level of
peripheral T cell expression of hCD2 from the BAC transgene (relative to the thymic levels)
seems to be improved over that seen from TCRα-LCR driven transgenes [5]. However, it is
necessary to point out that direct comparisons of hCD2 reporter gene expression from the BAC
construct and the TCRα-LCR driven transgenes have not yet been made.
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F IGURE 11. Reporter and endogenous TCRα mRNA levels in thymic and peripheral T
cells. (Left) qRT-PCR analyses of mRNA levels of (A) hCD2 reporter gene and (B)
endogenous TCRα gene in thymus (black bars) and purified spleen T cells (white bars) of
indicated transgenic BAC mice. Signals normalized to β-actin. Expression is graphed within
each line as a percentage of the thymic expression (set to 1.0). (Right) Graph on the right
represents averaged values from four BAC transgenic lines. Statistical analyses of the data
performed by using the two-tailed student’s t-test. No significant difference in (A) hCD2 or
(B) endogenous TCRα mRNA levels between thymus and spleen T cells is detected (p=0.115)
and (p=0.2106), respectively.

The endogenous TCRα expression in peripheral T cells, although not significantly higher than
thymic TCRα mRNA levels, reaches, on average, above the thymic levels, whereas peripheral T
cell expression of the transgene does not. Although we can’t rule out that the BAC is missing
some additional, yet unidentified, peripheral T cell “specific” cis-element(s) from the ~1.6-Mb
wide TCRα/δ locus [78], we currently do not favor this hypothesis. First, our WT BAC spans to
Jα2. Upon rearrangement of the most V-distal Jα region (Jα2) [79,80], the sequence upstream of
Jα2 is removed via recombination, yet the TCRα is efficiently transcribed; therefore any
indispensable element should be present downstream of Jα2 [53]. Second, a Rec-HY transgenic
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model closely mimics endogenous TCRα expression pattern including the periphery [81]. This
construct utilized modified pTαCass [53] vector, therefore includes equal sequence downstream
of Jα2, containing the entire TCR Cα region and full TCRα LCR (same as our WT BAC).
Contrary to our original hypothesis, the added intronic Jα2-Cα region, although clearly
functional in peripheral T cell expression (see chapter 6), does not seem differentially contribute
to peripheral vs. thymic expression. Our preferred hypothesis involves differential posttranscription regulation of the TCRα gene in thymus and periphery. Post-transcription regulation
occurs by short, cis-acting RNA elements, likely located in the 5’UTRs or 3’UTRs. Such
elements add additional complexity in regulation of gene expression by controlling the stability
of the mRNA [82]. Small, noncoding RNAs termed microRNAs (miRNAs) are able to target
their complementary sequences and alter expression of the gene. Therefore, if the endogenous
TCRα gene and hCD2 transgene are subject to different post-transcription regulation, we might
be detecting these small differences. However, this hypothesis needs further investigation.
In summary, our dual-reporter WT BAC shows appropriate spatiotemporal, TCRα-like
expression kinetics and ubiquitous, Dad1-like expression for its upstream and downstream
reporter, respectively, making it an ideal model for investigating the role of HS1’ in TCRα and
Dad1 expression.
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Chapter 5: Non-redundant role of HS1’ in thymic and peripheral expression of the TCRα
gene

5.1 Introducing the HS1’ site of the TCRα LCR

HS1’ is located 3’ of the classical enhancer Eα and the fine mapping positioned the HS1’ site 3’
of the BglII restriction site [20]. It does not display any enhancer activity as documented by
transient transfection experiments [16] and forms in both lymphoid and non-lymphoid organs
[17,20]. Transgenic mice analyses implicate the HS1’ region in maintaining the tissuedifferential chromatin structure (preferential, strong HS6 formation in thymus) and in
counteracting the wide chromatin-opening capacity of the 3’-end of the TCRα LCR located in
HS2-6 region, mainly in HS6 [17,20,22]. HS1’ is thought to possess tissue specificity that allows
for lymphoid-specific expression of the TCRα gene [15,20].
In 1997, the HS1’ region was included in the TCRα enhancer knock out (EαKO) mice that were
created to address function of the Eα in the regulation of the TCRα gene rearrangement and
expression [83]. The targeted region consisted of Eα enhancer and the neighboring cluster of
DNaseI HS, named HS1’ region [15,20]. This targeted deletion of the HS1 (Eα) and HS1’
sequences led to developmental block in thymocytes at the DP stage. This block is not complete
since small numbers (~20-fold reduction compare to wild type) of αβ T cells appear in periphery.
The repertoire of these cells is limited, utilizing mainly members of Vα2 family [83].
Furthermore, the deleted region is important for germline transcription from the T early alpha
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(TEA) promoter, Vα-Jα rearrangement and its transcription and proper expression of rearranged
TCRδ transcripts in γδ T cells [83].
The attempt to rescue the severe phenotype of the EαKO mice was made by returning sequence
of the murine Eα core back to the original EαKO allele in Eα core knock in mice (EαCRKI) [84].
Eα core sequence was chosen based on the homology to the human 116-bp (BstXI to DraI) Eα
sequence [85] rather than the somewhat larger 226-bp (PvuII to BglII) originally defined murine
Eα [16]. Results showed slightly enhanced Vα-Jα rearrangement, slightly elevated usage of the
5’ Vα gene segments but overall, EαCRKI mice do not show any significant improvement over
the original EαKO (HS1 and HS1’) phenotype [84]. This strongly argues for a great significance
of the HS1’ region.
In order to examine the non-redundant role of the HS1’ region we made a clean, internal deletion
of the HS1’ site in our dual-reporter BAC (Figure 12) allowing us to determine the role HS1’
plays in TCRα expression as well as in Dad1 regulation. The TCRα LCR’s influence on the
regulation of Dad1 gene has not yet been determined, but HS1’ site of the TCRα LCR is a
suitable candidate for its role in Dad1 regulation for the following reasons: its lies on the cusp of
the 5’-end (tissue specificity) [20] and 3’-end (suppression position effect/chromatin opening
capacity) [22]; it forms in both lymphoid and non-lymphoid organs [17,20]; and the unusual
arrangement of the non-homolougous genes (TCRα vs. Dad1) is evolutionarily conserved
(human, mouse, chicken) [78]. Furthermore, both TCRα and Dad1 have regulated gene
expression during the course of the T cell development, with highest expression levels occurring
at the SP stage of T cells [86].
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5.2 The mutant delta HS1’ dual-reporter BAC

In this study, we are utilizing a mutant version of our wild type BAC that has a internal deletion
of 826-bp between the BglII and BamHI restriction sites, removing the HS1’ site of the TCRα
LCR (Figure 12).
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F IGURE 12. Diagram (drawn not to scale) of the TCRα /Dad1 gene locus-derived dual
reporter BAC construct with HS1’ deletion. Two reporter genes in opposite transcriptional
orientations (indicated by horizontal arrows), genomic human CD2 (ghCD2) and rat CD2
(rCD2) are driven by the cognate Vα 17 and Dad1 promoters, respectively. Individual exons of
the ghCD2 reporter gene, TCRα constant region (Cα) and Dad1 gene are numbered and
depicted as dark boxes in the diagram. The large, light box represents the TCRα LCR
sequences consisting of nine DNaseI hypersensitive sites (HS). The numbered, vertical arrows
mark positions of individual HS of the TCRα LCR, namely HS 1-8. HS1 is the classical
transcriptional enhancer element of the TCRα gene, Eα. 3’ of the Eα is HS1 prime (HS1’).
Wild type and mutant delta HS1’ version were created. BglII and BamHI restriction sites mark
the borders of removed sequence in the HS1’ BAC mutant. The positions of the FseI and NotI
restriction sites used to excise the BAC reporter fragments for microinjection are also shown in
the diagram.

Initially, four wild type BACs and four mutant dHS1’ BAC transgenic lines were available.
However, two dHS1’ BAC founders failed to breed and left us with only two established mutant
lines. We are confident that our results are a representative sample since the initial flow
cytometry analyses of all four mutant dHS1’ lines are in agreement.
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5.3 hCD2 reporter gene expression is impaired in the absence of HS1’ site

Flow cytometry analysis was used to detect cell surface expression of the hCD2 reporter gene in
thymic cells from wild type and mutant dHS1’ BAC transgenic mice. The mean fluorescence
intensity (MFI) was used as a measure of the reporter gene expression. Thymic cells were gated
to the DP (CD4+/CD8+) population and MFI values for hCD2 reporter were divided by copy
number and normalized to MFI of the CD4+ cells. All four dHS1’ mutant BAC transgenic lines
5F, 20, 24F and 38 (copy number 7, 2, 15 and 3) showed copy number dependent hCD2
expression. The raw hCD2 MFI values per copy were within narrow 1.7 fold diference (data not
shown). Removal of HS1’ region leads to reduced levels of hCD2 expression (Figure 13). On
average, only 30% of the wild type levels (per copy) are observed in dHS1’ mutant.

F IGURE 13. Impaired hCD2 reporter expression is evident in four, independent HS1’
mutant BAC transgenic mouse lines. Mean fluorescence intensity (MFI) of hCD2 reporter
(per transgene copy) in gated DP thymocytes of wild type (black bars) and dHS1’ mutant
(white bars) BAC transgenics. Per copy reporter MFI was normalized to MFI of the CD4 and
graphed as percent of the maximal value. Two of the four mutant lines (M5F and M24F) are
analyzed founders that failed to establish transgenic line.
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Since LCRs are active at the transcriptional level, Northern blot and/or qRT-PCR assays are
more suitable methods, and are therefore employed for further analyses. We used both methods
to examine the effect of the HS1’ deletion on the expression levels of our reporter genes by
comparing mutant levels to wild type in thymus (Figure 14) and peripheral T cells isolated from
spleen (Figure 15).
In thymus, using Northern blot and PhoshorImager analyses, detected hCD2 and rCD2 mRNA
levels are normalized to the 18S rRNA levels, divided by the estimated relative copy number and
graphed as percentage of the higest expressing line. We detected a significant decrease of the
hCD2 reporter mRNA levels (per transgene copy) in mutant dHS1’ BAC that are on average
under 40% of the wild type BAC levels (2.6-fold lower). The second reporter gene, rCD2 is not
influenced by the deletion (Figure 14).
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F IGURE 14. Impaired hCD2 reporter expression in thymocytes of HS1’ mutant BAC
transgenic mice. (A) Northern blot analyses detecting the hCD2 and rCD2 reporter transgene
expression in thymus of multiple transgenic lines bearing either the wild type (n=4) or delta
HS1’ (n=2) BAC constructs. The non-transgenic littermate (ntg) control is included. Reporter
gene signal is normalized to 18S rRNA. Relative copy numbers of the individual transgenic
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mouse lines are indicated. (B&C) PhosphorImager analysis of Northern blot experiments in A.
The normalized, per copy mRNA levels of (B) hCD2 and (C) rCD2 reporter gene from wild
type (black bars) and HS1’ mutant (white bars) BAC are graphed as percentage of maximal
expression. (D) Statistical analyses of the above data using the two-tailed student’s t-test. The
asterisk indicates the statistical significance (p=0.0265) of the difference in hCD2 reporter
expression between the wild type and mutant. Whereas, no significant difference (p=0.44) in
rCD2 reporter expression was detected.

qRT-PCR analyses were utilized to determine the role HS1’ region plays in peripheral T cells.
MACS purified spleen T cells (purity >92%) were used for these analyses. We employed
endogenous mRNA expression levels of TCRα and Dad1 genes as our normalization controls for
the hCD2 and rCD2 reporter, respectively. Results are graphed in Figure 15 and show that
average transgene mRNA levels (per copy) of the upstream reporter (hCD2) are reduced over
3.2-fold from the wild type BAC levels when the HS1’ region is removed. Once again, removing
HS1’ doesn’t alter the levels of the rCD2 reporter mRNA as assayed per transgene copy.
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F IGURE 15. Peripheral T cells exhibit reduced hCD2 transgene expression in HS1’
mutants. qRT-PCR analyses of (A) human and (B) rat CD2 reporter transgene expression in
purified spleen T (SpT) cells isolated from wild type (black bars) and HS1’ mutant (white bars)
BAC transgenic mice. Per copy and normalized transgene mRNA levels are graphed relative to
the highest expressing line (as % maximum). The endogenous TCRα and Dad1 mRNA levels
were used as normalizers for the hCD2 and rCD2 reporter mRNA levels, respectively. Three
experiments performed in duplicates are presented. (C) Statistical analyses of the above data
using the two-tailed student’s t-test. Statistical significance of the difference in hCD2 mRNA
levels between wild type and HS1’ mutant BAC is marked by asterisk (p=0.027). In contrast,
no significant difference in rCD2 mRNA levels was detected (p=0.79).
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In summary, from our in vivo analyses of the dual-reporter BAC transgenic mice carrying the
HS1’ region deletion, we report that deletion has effects upstream but not downstream, impairing
the upstream hCD2 transgene activity in thymic and peripheral T cells but does not have a direct
role in Dad1 regulation.

5.4 Role of HS1’ in tissue specific expression in the context of the TCRα /Dad1 BAC

Endogenous expression of the TCRα gene is highly tissue specific, as is the hCD2 reporter gene
mRNA production under the control of the TCRα LCR [5,50]. In order to determine the role of
the HS1’ in tissue specificity in the context of the TCRα/Dad1 BAC, we compared mRNA
samples from lymphoid (thymus) and non-lymphoid tissue/organs of wild type and mutant BAC
transgenic mouse lines on Northern blots (expression of the rCD2 reporter c-DNA) or assayed by
qRT-PCR (ghCD2 expression).
Both wild type and dHS1’ BACs displayed the wild type tissue distribution of hCD2 mRNA
production, with highest expression in thymus and very low expression in non-lymphoid organs,
under 5% of the thymic expression (Figure 16A). The highest expression among the nonlymphoid representatives was observed in liver of the HS1’ BAC mutant, however its value was
merely 4.1% of thymic expression levels, it is well within the expected values. To our surprise,
we have not observed increased expression of the reporter gene in heart (or as a matter of fact,
any other examined organ) as was previously reported for single reporter transgenic analyses
[15]. It is possible that previously observed phenotypes resulted from “reverse” synergy of
multiple removed elements (specifically HS7, 8, Eα and HS1’) of the TCRα LCR. Present
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studies examine clean, uni-site deletion, leaving rest of the locus intact. However, this
discrepancy is most likely due to difference in reporter gene usage (β-globin vs. hCD2) and/or
choice of transgenic cassette (single reporter vs. BAC). Furthermore, transgenic analyses of the
β-globin transgene under influence of the HS2-6 elements from the TCRα LCR indicated more
favorable environment for the transgene expression in heart [20].
Positioning the rat CD2 reporter gene into the 1st exon of the Dad1 gene [50], allowed us to
determine any influence of the deleted region on Dad1 gene expression. Rat CD2 mRNA was
detected on Northern blot in all examined organs (Figure 16B), displaying a similar pattern of
ubiquitous expression in both wild type and mutant transgenic lines. Therefore, the transgene
expression pattern in mutant does not deviate from the consistent transgene expression pattern of
the wild type.
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F IGURE 16. Tissue distribution of hCD2 and rCD2 transgene expression remains unaltered
in HS1’ mutant. (A) qRT-PCR analysis of hCD2 transgene expression in the indicated
organs/tissue (thymus, kidney, lung, liver and heart). Averaged, β-actin normalized hCD2
transgene mRNA levels are graphed as percentage of thymic expression (set to 1.00) in wild
type (black bars) n=4 and HS1’ mutant (white bars) n=2 BAC transgenic mouse lines. (B)
PhosphorImager analyses of the rCD2 reporter mRNA signals from the indicated tissue/organ
detected on the Northern blot. Rat CD2 transgene levels are normalized to 18S rRNA and
expressed as a percentage of the organ with the highest level of reporter expression (%
maximum) within each transgenic line.
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5.5 Developmental timing of the dHS1’ BAC

We have not yet directly examined the onset of the hCD2 reporter gene in mutant dHS1’ BAC
transgenic mice. We did, however address this question using dHS1’ BAC ESC (clone D10).
This mutant ESC clone did not deviate in the onset of the hCD2 reporter gene expression from
its wild type counterpart. The onset of hCD2 expression was observed at the DN3 stage (data
not shown). Unfortunately, more positive dHS1’ BAC ESC clones with intact transgenes were
not generated, as the size of the BAC and the difficulties in its manipulation re-surfaced.
To overcome this obstacle, we utilized simpler and shorter transgene cassettes. The hCD2:1-8
construct was previously described in both in vivo [5] and in vitro [55] studies. As a matter of
fact, this particular construct was the one that was validated in the in vitro ESC differentiation
system for LCRs studies [55]. Therefore, control ESC clones carrying the hCD2:1-8 transgene,
generated by Dr. Armin Lahiji were ready for immediate use. We created constructs that had
deletion of the HS1’ region (Figure 17) and established independent ESC clones (see chapter 2).
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F IGURE 17. Diagram of single reporter transgene constructs used in vitro ESC
differentiation experiments. Scaled diagram of the hCD2:1-8 and hCD2:1-8dHS1’ transgene
constructs. The hCD2 reporter gene fragment is positioned 5’ of the TCRα LCR. White box
represents the Eα enhancer. Dark boxes represent individual exons of the hCD2 gene. Exon V
of the hCD2 gene has a premature stop codon (marked by x) that results in non-signaling CD2
molecule [5,51]. Horizontal arrow indicates the transcriptional orientation of the hCD2
reporter gene. The vertical arrows mark individual hypersensitive sites (HS) consisting the
TCRα LCR. Full length TCRα LCR (all 9 HSs) or mutant delta HS1’ constructs were used.
Deletion of 826-bp sequence (HS1’ region) between BglII and BamHI is marked by breakpoint
in continuity of line within the TCRα LCR.

Seven hCD2:1-8dHS1’ ESC clones were in vitro differentiated alongside a non-transfected
ESR1 (negative control) and wild type hCD2:1-8 control (clones FA1, FB5 and FD6 [55]. All
seven clones showed no hCD2 expression in monocytic or erythroid cells (Figure 18 and data
not shown) as expected. Six out of seven clones display TCRα-like expression of the reporter
gene with expression onset at the DN3 stage of the T cell development (Figure 18 and data not
shown). We have obtained one ESC clone (N3) that exhibits aberrant, early onset of the hCD2
reporter gene expression at DN1 stage. Since this phenotype occurred only in a single clone, we
believe that this particular clone is experiencing a positive position effect at the site of
integration. The endogenous hCD2 gene (under control of its own regulatory elements) starts
expression at DN1 stage [87].
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F IGURE 18. Flow cytometry analyses of copy number matched ESC clones during in vitro
ESC differentiation. hCD2 reporter transgene activity of hCD2:1-8 construct (clone FB5,
FA1) [55] and mutant hCD2:1-8ΔHS1’ construct (clones N1,N3 and L2) are shown. FB5 and
N1, N3 carry 2 copies (left); FA1 and L2 are a single copy integrants (right). Representative
gating is shown far left. Cells collected on day 12, 16 and 20 of co-culture. hCD2 reporter gene
expression in transfected (dark line) and non-transfected (light line) in vitro derived cells is
shown in each histogram.
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In summary, neither the in vivo nor in vitro analyses of constructs with HS1’ deletion revealed
aberrant tissue distribution of the hCD2 reporter gene expression. The transfected ESC clones we
have in hand at present only enable in vitro comparisons of spatiotemporal expression patterns
between the wild type and HS1’ mutant reporter transgene constructs. Further quantitative
analyses comparing the expression level of the reporter gene (per transgene copy) in the wild
type and dHS1’ ESC clones will require creation of additional wild type ESC clones with higher
copy numbers that better match the range obtained for the mutant ESC clones. This is needed to
rule out the possibility that transgene expression becomes saturated at high copy in our in vitro
system.
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Chapter 6: Novel TCRα gene cis-regulatory region

6.1 Introduction

The great diversity of TCRs is achieved through the V(D)J recombination process that utilizes
multiple variable (V), diversity (D) and joining (J) gene segments of the TCRβ and TCRα loci,
residing on mouse chromosomes 6 and 14, respectively. Alpha and beta chains combine to form
complete mature αβ T cell receptors (TCRs) that the vast majority of T cells carry. The TCRα
genes share their locus with TCR δ genes that are embedded between the Vα and Jα segments.
Upon rearrangement, TCR δ segments are deleted. The complex TCRα/δ gene locus is tightly
cis-regulated by the elements within the TCRα Locus control region (LCR) located 3’ of the
constant region (Cα). LCRs are thought to act on the chromatin level to achieve the appropriate
expression mode employing epigenetic markings [21,29,88].
HS1 and HS1’ regions are key players to achieve enhanced T cell specific transcription of the
TCRα gene [15,83] and to regulate the V(D)J recombination, transcription of the germline
sequences and of the rearranged genes [83]. Removal of the HS1 and HS1’ sites has a hard
impact on these processes as discussed in chapter 5. However, limited TCRα gene recombination
is still observed even without the Eα/HS1’ elements. Peripheral populations of αβ T cells, though
of limited antigenic variety, are observed. Expression of the mature TCRα transcripts is lowered
but present [83]. Therefore as suggested, other elements of the TCRα/δ locus are responsible for
allowing accessibility and transcriptional activation. Enhancer Eδ must be excluded from the
potential pool of elements since it’s excised upon Vα-Jα rearrangement as mention above.
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Since the TCRα LCR consists of 9 HS sites (see introduction), the remaining elements might
have been possible candidates. However, wider search for appropriate candidate is necessary
since it has been documented that although powerful in bring TCRα-like expression to the
heterologous transgenes in thymus [5,55] it’s lacking in periphery [5]. Therefore, a wider scope
in the search for additional elements is necessary.

6.2 Multiple DNaseI hypersensitive sites are detected 3’ of Jα 2

In rearranging thymocytes, the most Vα-distal functional joining (J) region that undergoes
rearrangement is Jα2 [79,80]. Upon V-J rearrangement of the TCRα gene, sequences 5’ of the
Jα2 are subject to deletion. Therefore, regulatory regions required for proper TCRα transcription
should reside downstream of Jα2 [53]. To identify potential regulatory DNA within this region,
we performed DNaseI hypersensitivity assays (DHA) on isolated nuclei from purified spleen T
cells. A cluster of hypersensitive sites (HS) was revealed in a DNA region stretching from Jα2 to
Cα1 (Figure 19). The most prominent of these is located near the Jα1 pseudogene (HS-J1).
Flanking HS-J1 are four weaker HS. Two of these approximately map to the Jα2-Jα1 region. The
third HS lies within the Jα1-Cα1 intron and the fourth localizes to the Cα1 exon (Figure 19
bottom). Since the Jα1 region is a non-functional pseudogene and is not transcribed due to
defective DNA recombination signals and RNA splicing signals [79], the detected array of active
chromatin would remain in all functionally rearranged TCRα genes.
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F IGURE 19. DNase I hypersensitivity sites (HS) within the Jα 2 to Cα 1 region. (A) Spleen T
cell nuclei from C57BL/6N mouse were subjected to DNaseI titration. Arrows indicate the
positions of the 6.7-kb NdeI parent fragment and HS. Results from two independent,
representative experiments are shown. (B) Scaled diagram of the approximate locations of
detected HS (arrows). The thick arrow near Jα 1 indicates the most prominent HS.
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To assess the contribution of the deleted sequence to the expression of the TCRα and Dad1
genes, we created a mutant version of our wild type dual-reporter TCRα/Dad1 BAC construct
(WT described in chapter 3). The mutant BAC (named Vα17ghCD2_rCD2_ΔJα3-Cα1) is
missing ~3.9-kb sequence (~SacI to EcoRV, covering region from upstream of Jα3 to Cα1) that
includes the five HS identified in the cluster (Figure 20). Independent transgenic mouse lines of
ΔJα3-Cα1 mutant BAC were obtained.
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F IGURE 20. Diagram (not to scale) of the Δ Jα 3-Cα 1 mutant TCRα /Dad1 dual-reporter
BAC construct. Horizontal arrows indicate the orientation of the two reporter genes. A Vα17
promoter drives expression of a genomic human CD2 reporter gene (ghCD2). The rat CD2
reporter is driven by the Dad 1 promoter. Vertical arrows indicate the location of the HS of the
TCRα LCR (including the TCRα enhancer, Eα). The 3.9-kb region deletion in the mutant BAC
is marked and runs from 38-bp 5’ of the SacI site through 30-bp 5’ of the end of Cα exon 1.

6.4 Flow cytometry detection of phenotypic differences in reporter gene expression
between wild type and Δ Jα 3-Cα 1 mutant BAC transgenic T cells

Flow cytometry analyses were used to detect cell surface expression of both human and rat CD2
reporter genes in T cells from wild type and mutant BAC transgenic mouse lines. Four wild type
and four mutant lines were assayed on per cell bases. Expression of both reporters was observed
in all transgenic mouse lines (Figure 21). However, hCD2 reporter expression seemed impaired
in T cells from the mutant BAC transgenic lines (Figure 21 3rd column from left). The observed
hCD2 expression levels on a per cell basis variegated in the mutant BACs, whereas the wild type
BACs showed tighter, uniform per cell hCD2 expression. The expression of the rCD2 reporter
gene was detected at low but uniform levels, indicating no involvement of the deleted region in
the Dad1 expression. To further investigate the severity of the observed variegated expression
phenotype of the hCD2 reporter gene at the mRNA level, additional quantitative analyses were
performed and transgene expression assayed on per copy basis.
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F IGURE 21. Impaired hCD2 reporter expression in the absence of the deleted region. Flow
cytometry analyses of human CD2 (hCD2) and rat CD2 (rCD2) reporter gene expression in
spleen T cells (TCRβ + ) from the indicated, independent wild type (Wt) and mutant (Mt) dualreporter BAC transgenic mouse lines. Reporter gene expression in transgenic (solid line) and
non-transgenic control (dashed line) cells is shown.
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6.5 Deletion of the Jα 3-Cα 1 region impairs Vα promoter-driven hCD2 reporter
gene expression in thymocytes and spleen T cells

We compared reporter gene mRNA expression levels observed in T cells (both thymic and
peripheral) isolated from four wild type and four Jα3-Cα1 mutant BAC transgenic lines using
Northern blot (Figure 22) and qRT-PCR analyses (Figure 23).
Human and rat CD2 mRNA levels were normalized to 18S ribosomal RNA and quantified by the
PhosphorImager. We detected decreased mRNA expression levels (per transgene copy) of the
hCD2 reporter in the mutant BAC transgenic lines that was on average 3.3 times lower than the
counterpart wild type (Figure 22). In contrast, the rCD2 reporter mRNA expression levels (per
transgene copy) appear unaffected.
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F IGURE 22. Absence of the deleted region impairs upstream, but not downstream reporter
gene expression in thymocytes. (A) Northern blot analyses of human and rat CD2 reporter
gene mRNA levels in thymocytes from the indicated lines of wild type and mutant reporter
BAC transgenic mice. 18S rRNA signals are used as a loading control. Relative transgene copy
number for each mouse line is indicated. Panels B and C depict PhosphorImager analyses of
the human CD2 (B) and rat CD2 (C) reporter mRNA signals detected by northern blots. The
normalized mRNA levels (per transgene copy) from each wild type (black bars) and mutant
(white bars) transgenic mouse line are graphed relative to each other (as % maximum). (D)
Statistical analyses of the above data using the two-tailed student’s t-test. The asterisk
indicates the statistical significance of the difference in hCD2 mRNA levels between wild type
and mutant BAC (p=0.012). In contrast, no significant difference in rCD2 mRNA levels was
detected (p=0.942).
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Similar results were obtained from mRNA analyses performed on the purified spleen T cells
(Figure 23). Levels of hCD2 mRNA (per copy of the transgene) in the mutant ΔJα3-Cα1 BAC
were on average 4.9 times lower than the wild type. The mRNA expression levels (per transgene
copy) of the second reporter gene rCD2, were not affected by the deleted region. These data
indicate that the deleted Jα3-Cα1 sequence plays a role in TCRα gene regulation in thymus as
well as in periphery.

60

F IGURE 23. The deleted region is functional in peripheral T cells. qRT-PCR analyses of
human (A) and rat (B) CD2 reporter gene mRNA levels in isolated spleen T cells (SpT) from
the indicated lines of wild type (black bars) and mutant (white bars) transgenic mice. Observed
reporter mRNA levels per copy from each transgenic line are graphed relative to each other (as
% maximum). hCD2 reporter mRNA levels were normalized to endogenous TCRα mRNA
levels, and rCD2 expression were normalized to endogenous Dad1 mRNA levels using primers
that detect sequences not present in the reporter BAC. Three experiments were performed in
duplicates. (C) Statistical analyses of the above data using the two-tailed student’s t-test. The
asterisk indicates the statistical significance of the difference in hCD2 mRNA levels between
wild type and mutant BAC (p=0.0159). In contrast, no significant difference in rCD2 mRNA
levels was detected (p=0.8188).
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Chapter 7: Discussion and Significance

7.1 Role of HS1’ in the TCRα locus

HS1’ differs from HS1 (Eα). The latter exhibits classical enhancer activity [16], whereas the
former does not and is thought to function in chromosomal context, in that it restricts the open
chromatin conformation of the TCRα locus to the lymphoid organs [15]. Yet, much of the
information accumulated comes from data where both elements were included (as discussed in
detail in chapter 5). Moreover, deletion analysis of TCRα LCR (progressing from the 5’ to 3’ and
removing HS7, HS8; HS1; and finally HS1’) in transgenic mice characterizes HS1’ function to
be of great importance for high-level, lymphoid-specific gene expression [15]. Since both HS1
and HS1’ were removed, these analyses resulted in loss of copy number dependence (Eα
removal) and very low levels of reporter expression in thymus, reaching only <1% of
endogenous TCRα signal for two-single copy transgenic mouse lines; 14-60% for the multicopy
lines [15]. Therefore, our dual-BAC model provided the opportunity to characterize the HS1’ site
in a non-redundant fashion. Furthermore, including reporter genes on either side of the TCRα
LCR, thereby mimicking the native locus, gave us the opportunity to determine the role of HS1’
in Dad1 expression.
Our dHS1’ BAC transgenic mice allowed us to examined the non-redundant role of HS1’ region
in transcriptional regulation of the TCRα locus. We have shown that deletion of the HS1’ region
leads to lower expression of the TCRα reporter (reduction 2.6-fold in thymus and 3.2-fold in
peripheral T cells). While markedly decreased expression of the TCRα reporter was observed,
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tissue specificity and integration site independence remained unaltered. While these data clearly
demonstrate the non-redundant, and significant, function of the HS1’ region, it is surprising,
given prior data, that the transcription deficits in the absence of HS1’ are not more severe.
Previous studies demonstrated the significant importance of the 1.15-kb (PvuII to BamHI) region
(that includes both HS1 and HS1’ sites) for T cell development progression, rearrangement and
TCRα expression (germline as well as mature transcripts) [83]. Specifically, Northern blot
analyses of total RNA from the HS1/HS1’ KO thymocytes failed to detect germline transcripts
initiated from the TEA as well as Cα-hybridizing transcripts. Mature transcripts (from spleen)
were detected but were about 6-fold lower than the wild type [83]. Since these EαKO studies
lacked both elements, it was impossible to discern which HS site is responsible for the defects.
Returning the 116-bp murine Eα core region to the EαKO allele, approximated HS1’ deletion in
the Eα core knock in mice (EαCRKI) [84]. This allele also bears an additional deletion of ~110bp of the non-core Eα region. Since EαCRKI mice show only slight improvement (in an
increased utilization repertoire of variable gene segments, mainly from the Vα2 family [84]),
over the defects seen in EαKO, the apparent importance of the HS1’ region and/or the remaining
~110-bp of the non-core Eα region emerges. Since we examined the effects of the removal of the
HS1’ region alone in BAC transgenic mice, and did not observe as dramatic an impairment as
prior data predicted, our data points into a new direction and calls for further dissection of the
potential role of 110-bp large sequence outside of the murine Eα core in TCRα gene regulation.
Furthermore, although our BAC study did not address rearrangement per se, HS1’ region and the
CTCF site residing in emerges as crucial for rearrangement of the TCRα locus, and the
mechanism is described in the below paragraphs.
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HS1’ has CTCF-dependent enhancer blocking insulator activity [18]. CTCF is a ubiquitously
expressed zinc-finger protein, involved in looping and long-range chromosomal interactions; a
common theme involved in insulation [89]. Co-localization of cohesin and CTCF has been
shown in many genomic sites [90]. Indeed, cohesin colocalizes with CTCF present in the HS1’
site as well [91,92]. Cohesin, originally known for its role in keeping sister chromatids together
during cell division [93], was also shown to play a role in rearrangement of the TCRα locus
[91,92,94]. Cohesin bindings sites were found in TEA, multiple V gene promoters and at Dad1
gene. In addition to binding to CTCF site in HS1’, cohesin has also been found to bind in a
region between TCRα and Dad1 genes [92], where CTCF-independent enhancer-blocking
activity was found (HS2-6 region) [18]. Binding of cohesin in these two insulator regions
signifies its importance and calls for further exploration of its role in this locus. In order to
understand the role of CTCF and cohesin, one must appreciate the fact that although CTCF
binding can be controlled by DNA methylation status [95], CTCF is ubiquitously expressed and
therefore not stage-specific or cell/tissue specific.
Cohesin, which displays a more stage-specific binding pattern [96] is most likely responsible for
the developmental stage-specific contraction of the TCRα locus as shown by 3D-FISH analyses
[31,33].
The role of cohesin in TCRα rearrangement was addressed in an elegant experiment, where Rad
21 (major subunit of cohesin) was conditionally deleted at the DP stage of T cell development. T
cells pause their cell cycle at the DP stage in order to undergo TCRα chain rearrangement,
therefore deletion of cohesin at this stage allowed for separation of its role in cell division from
that in rearrangement [92]. The results of these experiments added to the existing evidence for
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role of CTCF and cohesin in TCRα rearrangement.
Cohesin-deficient T cells showed reduction of germline Jα transcription that in turn led to
reduction of histone H3 lysine 4 trimethylation (H3K4me3) mark [92]. Methylation marks can be
deposited to the J arrays of TCRα locus during germline transcription initiated at TEA since
histone methyltransferases can travel with elongating RNA Pol II complex [97]. Germline
transcription and trimethylation of H3K4 has been shown to induce accessibility of the TCRα/δ
locus to the recombination machinery [98]. RAG2 binds to H3K4me3 [99], hence decrease in
H3K4me3 leads to reduced recruitment of RAG2 and impairment of rearrangement. Therefore,
CTCF and cohesin control contraction of the TCRα locus, that in linear DNA sequence would be
too far apart, allows for orderly rearrangement.
Location of HS1’ between the 5’ tissue specific and 3’ chromatin opening sub-elements of this
locus, presence of CTCF and cohesin sites, and enhancer blocking activity points to the role of
HS1’ in prevention of inappropriate cross talk between multiple elements of the complex
TCRα/δ/Dad 1 locus. However, it is not clear yet how and what individual elements of the TCRα
LCR contribute in insulating the two differentially expressed genes residing on either side. We
hypothesized the role of HS1’ in regulation of Dad1 gene (see chapter 5). However, our results
did not show a difference in rCD2 expression (at the position of Dad1) upon removal of HS1’.
One possible reason for our results is that there may be redundancy in this locus since both genes
play a vital role.
It has been shown that deletion of cohesin results in increased readout of Dad1 and Cδ transcript
at the expense of Cα transcript [92]. Therefore, the functional separation between TCRα and
Dad1 genes was lost in cohesin depleted T cells [91,92]. Since our BAC investigated the HS1’
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role in Dad1 regulation and no increased expression of rCD2 reporter (Dad1) was found, this
observed increase of Dad1 transcripts must be due to lost boundary other than HS1’; therefore,
other site(s) in the HS2-6 region are responsible for this insulator function. Two additional sites,
HS4 and HS6 showed dependence on HS1’, in that HS1’ was necessary for lymphoid specific
hypomethylation of HS4 [21] and for the occupancy of tissue specific factors in HS6 [22] are
strong candidates for additional function. Cohesin is required for formation of this boundary that
limits Eα enhancer activity to TCRα locus in DP T cells [91,92].

F IGURE 24. HS1’ is not required for Dad1 regulation. In the absence of HS1’ site (dHS1’
BAC construct), no altered rCD2 (Dad 1) is observed. Therefore, other element(s) within the
HS2-6 are capable of insulator (enhancer blocker) function.

Dad1 gene expression is upregulated at the SP stage of the T cell development [86], as is the
endogenous expression of TCRα. It has been also indicated that N-linked glycosylation is
necessary for optimal cell surface expression of TCRα [100]. However, due to the relevance of
apoptosis during T cell development, the upregulation of Dad1 (anti-apoptotic gene) at the SP T
cell stage (after positive selection that removes majority of unsuitable thymocytes) might be
under the control of the TCRα LCR. It would be interesting to investigate the element(s) of the
TCRα LCR that (and in what combination) are important players in insulating the expression of
these two genes in a developmentally orchestrated manner.
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7.2 Novel TCRα gene cis-regulatory region

Utilizing the DNaseI hypersensitivity assay, we have identified region of active chromatin 5’ of
the Cα constant region. The identified cluster comprises of a few HS sites with the most
dominant site adjacent to the non-functional pseudogene Jα1 [79,80]. Previous studies indicated
presence of additional element(s) to the Eα and HS1’ regions in the TCRα/δ locus that would be
able to facilitate accessibility and transcriptional activation of the locus [83] (see chapter 6). The
discovery of a novel cluster of HS sites in this region may provide an explanation for the
surprising residual TCRα gene activity observed in the EαKO mice. The location of this cluster
is interesting from a few perspectives. First, it is located 3’ of the most Vα-distal functional J
segment (Jα2) [79,80]. Therefore it will remain present in the locus upon any functional V-J
rearrangement. Second, its position 5’ of the Cα completes the “flanking” of Cα from both sides:
our novel cis-acting element occupies the 5’ end of the Cα while the classical Eα enhancer is
located on the 3’ end. This particular arrangement of cis-acting enhancer-like elements 5’ and 3’
of the constant region exons is also observed in many large antigen loci, e.g. the IgH [101], Igκ
[102], TCRγ [103] and TCRδ [6].
The location of the µ and κ enhancers within the intronic Jα-Cα region inspired the search for the
human TCRα enhancer ~25 years ago [104]. Utilizing a CAT assay, enhancer activity was
reported for the Jα_Cα intronic region in the human TCRα locus [104]. Subsequently, the
enhancers for the mouse and human TCRα locus were found on the 3’ end of the Cα [16,85].
Individual segments 5’ of the Cα1 were included in testing for classical enhancer activity but
failed to reveal any, categorizing our element as a cis-acting DNA element without classical
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enhancer activity. We have demonstrated its functionality in vivo in the context of transgenic
animals.
A single locus can harbor multiple cis elements playing unique or redundant roles as seen in a
particularly intriguing example coming from the IgH locus. The intronic Eµ enhancer plays a key
role in the V(D)J rearrangement [101] whereas the 3’ enhancer is implemented in class
switching. However, it was also found that Eµ plays a nonessential role in both class-switch
recombination and somatic hypermutation [105], exhibiting an overlapping function with the 3’
regulatory element [106]. Furthermore, relieving Eµ’s responsibilities in V(D)J recombination
(by inserting pre-rearrange cassette) revealed Eµ’s role in allelic exclusion [107]. Analyses of the
VDJ knock-in/Eµ KO mice [107] pointed to faulty clonal selection and generation of
autoimmune B cell clones [108], detrimental to an organism’s immunity. Therefore the above
example not only points to a complexity of the regulation of the antigen receptor loci but also to
great importance of identifying and functionally dissecting multiple cis-acting elements, residing
in a locus (regardless of its overlapping or redundant appearance). The in vivo assayed novel cisacting regulatory complex 5’ of Cα adds yet other region of the TCRα locus that has a potential
to participate in complex gene regulation of assembly, timing and expression level leading to
functional, antigen recognizing immune cells, key players of adaptive immunity.
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